A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who have not responded to previous hypomethylating agent therapy

Overview of attention for article published in British Journal of Haematology, August 2019

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
Good Attention Score compared to outputs of the same age (78th percentile)
Good Attention Score compared to outputs of the same age and source (77th percentile)

Mentioned by

twitter: 16 X users

Readers on

mendeley: 16 Mendeley

So far, Altmetric has seen 19 X posts from 16 X users, with an upper bound of 74,506 followers.

RT @garciamanero: A phase II study of addition of pracinostat to a hypomethylating agent in patients with myelodysplastic syndromes who hav…

#MDSsm

This page shows the most recent X posts that mention this research output. Click here to find out how to access more activity, including 15 additional X posts.